SF3A3P2

Across TCGA pan-cancer cohorts, SF3A3P2 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated SF3A3P2 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher SF3A3P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SF3A3P2 expression acts as an unfavorable survival marker, although some lineages such as SKCM and UCS show a favorable association.

LUAD, LIHC, and KICH are the cancer types where SF3A3P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.626	0.778	.001	75	view →
LIHC	DFS	Quartile	All	0.305	0.489	<.001	58	view →
KICH	OS	Quartile	III,IV	0.178	0.844	.005	51	view →
SKCM	OS	Quartile	II,III,IV	0.630	0.188	<.001	42	view →
MESO	DFS	Median	IV	0.162	0.454	.001	42	view →
ACC	DFS	Median	All	0.176	0.622	<.001	40	view →
STAD	OS	Tertile	II,III,IV	0.589	0.830	.016	27	view →
BRCA	OS	Tertile	II,III,IV	0.496	0.607	.008	26	view →
UCS	DFS	Tertile	IV	0.996	0.401	.024	24	view →
COAD	OS	Tertile	IV	0.867	0.308	.004	20	view →
PRAD	DFS	Tertile	All	0.926	0.774	.006	12	view →
KIRP	DFS	Median	All	0.918	0.651	.029	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

SF3A3P2–LUAD (OS)

Open the LUAD breakdown →